These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9431025)

  • 1. Synthesis and neuropeptide Y Y1 receptor antagonistic activity of N,N-disubstituted omega-guanidino- and omega-aminoalkanoic acid amides.
    Müller M; Knieps S; Gessele K; Dove S; Bernhardt G; Buschauer A
    Arch Pharm (Weinheim); 1997 Nov; 330(11):333-42. PubMed ID: 9431025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonists.
    Dove S; Michel MC; Knieps S; Buschauer A
    Can J Physiol Pharmacol; 2000 Feb; 78(2):108-15. PubMed ID: 10737673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures.
    Aiglstorfer I; Uffrecht A; Gessele K; Moser C; Schuster A; Merz S; Malawska B; Bernhardt G; Dove S; Buschauer A
    Regul Pept; 1998 Sep; 75-76():9-21. PubMed ID: 9802389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
    Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
    J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
    Wieland HA; Willim KD; Entzeroth M; Wienen W; Rudolf K; Eberlein W; Engel W; Doods HN
    J Pharmacol Exp Ther; 1995 Oct; 275(1):143-9. PubMed ID: 7562543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure, and antagonistic properties of des-Asn29[D-Trp28,32]NPY(27-36).
    Balasubramaniam A; Zhai W; Tao Z; Huang Y; Fischer JE; Eden P; Taylor JE; Kar L; Samarasinghe SD; Johnson ME
    Peptides; 1996; 17(7):1113-8. PubMed ID: 8959744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining structural requirements for neuropeptide Y receptors using truncated and conformationally restricted analogues.
    Kirby DA; Koerber SC; Craig AG; Feinstein RD; Delmas L; Brown MR; Rivier JE
    J Med Chem; 1993 Feb; 36(3):385-93. PubMed ID: 8426366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,3-Disubstituted benzazepines as novel, potent, selective neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hara H; Okada T; Hashizume H; Kii M; Ishihara Y; Ishikawa M; Shimamura M; Mihara S; Kato G; Hanasaki K; Hagishita S; Fujimoto M
    J Med Chem; 1999 Jul; 42(14):2621-32. PubMed ID: 10411482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of impromidine- and arpromidine-derived guanidines on recombinant human and guinea pig histamine H1 and H2 receptors.
    Xie SX; Schalkhausser F; Ye QZ; Seifert R; Buschauer A
    Arch Pharm (Weinheim); 2007 Jan; 340(1):9-16. PubMed ID: 17206612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
    Buschauer A
    J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
    Buschauer A; Mohr R; Schunack W
    Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
    Weiss S; Keller M; Bernhardt G; Buschauer A; König B
    Bioorg Med Chem; 2008 Nov; 16(22):9858-66. PubMed ID: 18851917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure activity relationship of guanidines as NPY Y5 antagonists.
    Aquino CJ; Ramanjulu JM; Heyer D; Daniels AJ; Palazzo F; Dezube M
    Bioorg Med Chem; 2004 May; 12(10):2691-708. PubMed ID: 15110851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.
    Keller M; Weiss S; Hutzler C; Kuhn KK; Mollereau C; Dukorn S; Schindler L; Bernhardt G; König B; Buschauer A
    J Med Chem; 2015 Nov; 58(22):8834-49. PubMed ID: 26466164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,3-Disubstituted benzazepines as neuropeptide Y Y1 receptor antagonists.
    Murakami Y; Hagishita S; Okada T; Kii M; Hashizume H; Yagami T; Fujimoto M
    Bioorg Med Chem; 1999 Aug; 7(8):1703-14. PubMed ID: 10482462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonistic properties of centrally truncated analogs of [D-Trp(32)]NPY.
    Balasubramaniam A; Ujhelyi M; Borchers M; Huang Y; Zhai W; Zhou Y; Johnson M; Sheriff S; Fischer JE
    J Med Chem; 1996 Mar; 39(5):1142-7. PubMed ID: 8676351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of neuropeptide Y Y1 receptor antagonists related to BIBP 3226.
    Aiglstorfer I; Hendrich I; Moser C; Bernhardt G; Dove S; Buschauer A
    Bioorg Med Chem Lett; 2000 Jul; 10(14):1597-600. PubMed ID: 10915060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
    Sautel M; Rudolf K; Wittneben H; Herzog H; Martinez R; Munoz M; Eberlein W; Engel W; Walker P; Beck-Sickinger AG
    Mol Pharmacol; 1996 Aug; 50(2):285-92. PubMed ID: 8700135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
    Abounader R; Villemure JG; Hamel E
    Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.